EGFR and glioblastoma: Our findings demonstrate that EGFR wild-type (WT) GBM cells exhibit sensitivity to BAY2402234 treatment and undergo changes in lipid droplet metabolite abundance, highlighting the importance lipid utilization in drug resistance.